[Information around organized breast cancer screening. Do INCa and Cancer Rose meet criteria for decision aids?]

Rev Epidemiol Sante Publique. 2020 Feb;68(1):33-36. doi: 10.1016/j.respe.2019.09.011. Epub 2019 Dec 12.
[Article in French]

Abstract

Background: Controversies around organized breast cancer screening emphasize the need for information for women. In France, the institute of cancer (INCa) is in charge of conveying this information. Cancer Rose's website (CR) provides complementary information considering INCa's incomplete. The objective of this study was to identify if these informations meet criteria for decision aid.

Methods: Information documents were selected and analyzed using International Patient Decision Aid Standards (IPDAS). Each item was noted A (absent), P (present) or I (present but incomplete).

Results: Information booklet and press kit for INCa and studies section for CR were the document meeting most criteria. The document meeting fewer criteria were the INCa's video and information leaflet for CR. Videos are more accessible tools for people with lower levels of health literacy. INCa's video did not present the risks of screening and CR's emphasized the risks.

Conclusion: These documents have not been evaluated for intelligibility, clarity and readability. Addressing these criteria limits social inequities and improves health literacy.

Keywords: Breast cancer; Cancer du sein; Communication; Dépistage; Prise de décision partagée; Screening; Shared decision making.

Publication types

  • Evaluation Study

MeSH terms

  • Academies and Institutes / organization & administration*
  • Academies and Institutes / standards
  • Access to Information
  • Breast Neoplasms / diagnosis*
  • Decision Making
  • Decision Support Techniques*
  • Early Detection of Cancer / methods
  • Early Detection of Cancer / standards
  • Female
  • France
  • Health Promotion / organization & administration*
  • Health Promotion / standards
  • Humans
  • Mass Screening / methods
  • Mass Screening / organization & administration*
  • Mass Screening / standards
  • Patient Participation / methods*
  • Patient Participation / statistics & numerical data
  • Reference Standards